Gujarat, India

Saurin Khimshanker Raval

This inventor holds 1 USPTO granted patent. Top assignee: Cadila Healthcare Limited. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Saurin Khimshanker Raval. Retrieved from https://idiyas.com/inventor/saurin-khimshanker-raval

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Saurin Khimshanker Raval: Innovator in Pharmaceutical Chemistry

Introduction

Saurin Khimshanker Raval is a notable inventor based in Gujarat, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with hypolipidemic and hypocholesteremic activities. His work is essential in advancing medical treatments and improving health outcomes.

Latest Patents

Saurin holds a patent for "Heterocyclic compounds having hypolipidemic, hypocholesteremic activities process for their preparation and pharmaceutical compositions containing them and their use in medicine - Novel β-aryl-α-substituted propanoic acids having hypolipidemic and hypocholesteremic activities." This patent highlights his innovative approach to creating effective pharmaceutical compounds.

Career Highlights

Saurin is currently associated with Cadila Healthcare Limited, a prominent player in the pharmaceutical industry. His role at the company allows him to apply his expertise in developing new medications that can significantly impact patient care.

Collaborations

Throughout his career, Saurin has collaborated with talented professionals, including Braj Bhushan Lohray and Vijay Kumar Gajubhai Barot. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Saurin Khimshanker Raval's contributions to pharmaceutical chemistry are noteworthy, and his patent reflects his commitment to advancing medical science. His work continues to inspire future innovations in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…